---
title: "Amphetamine Mixed Salts (Adderall) Tablet Shortage: February 2026 Update"
summary: "The FDA reports ongoing supply disruptions for amphetamine mixed salts tablets, with several manufacturers experiencing limited availability or total stockouts through early 2026."
category: "drug-shortages"
tags: ["drug-shortage","fda","medication","Amphetamine","Adderall","Tablet","Psychiatry"]
location: "United States"
severity: "medium"
sourceUrl: "https://www.accessdata.fda.gov/scripts/drugshortages/default.cfm"
sourceAgency: "FDA"
publishedAt: 2026-02-11T14:37:45.000Z
---
## What's in Shortage

The FDA has updated the status of the shortage involving **Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, and Dextroamphetamine Sulfate Tablets**. This medication, commonly known by the brand name **Adderall**, is a therapeutic agent used in the field of **Psychiatry**. The shortage affects various strengths of the tablet dosage form. While some presentations remain available, many manufacturers are reporting limited supplies or total unavailability.

**Initial Posting Date:** 10/12/2022  
**Last Updated:** 02/04/2026

## Which Manufacturers Are Affected

Supply status varies significantly by manufacturer and specific dosage strength:

*   **Alvogen**: 
    *   **Unavailable**: 20mg (est. 2/20/2026), 30mg (est. 3/6/2026), and 5mg (est. 2/20/2026).
    *   **Limited Availability**: 15mg and 10mg (supporting contracted volume only).
    *   **Contact**: 844-842-8672 or CustomerService-US@alvogen.com

*   **Elite Laboratories, Inc.**: 
    *   **Limited Availability**: 1.25mg, 7.5mg, 3.75mg, 1.875mg, 2.5mg, 3.125mg, and 5mg strengths (estimated 3-month duration).
    *   **Contact**: 888-852-6657

*   **Teva Pharmaceuticals USA, Inc.**: 
    *   **Available**: Various strengths of Adderall and generic tablets (1.25mg, 2.5mg, 3.75mg, 1.875mg, 3.125mg).
    *   **Limited Availability**: 5mg (est. recovery Jan 2026), 7.5mg (est. recovery Feb 2026), and 3.75mg (est. recovery Feb 2026).
    *   **Contact**: 800-545-8800

*   **Sandoz Inc.**: 
    *   **Available**: 1.25mg.
    *   **Limited/Unavailable**: 2.5mg, 5mg, and 7.5mg strengths are facing intermittent backorders in Q1 and early Q2 2026.
    *   **Contact**: 800-525-8747

*   **SpecGx LLC**: 
    *   **Available**: 7.5mg, 5mg, 3.75mg, 1.25mg, 2.5mg, and 1.875mg strengths.
    *   **Contact**: 800-325-8888

*   **Epic Pharma, LLC**: 
    *   **Available**: 2.5mg, 3.75mg, 5mg, and 1.25mg.
    *   **Unavailable**: 7.5mg (estimated availability in 2 weeks).
    *   **Contact**: (718) 276-8600 ext. 3

*   **Lannett Company, Inc.**: 
    *   **Available**: 2.5mg, 1.875mg, 1.25mg, 7.5mg, 3.75mg, 3.125mg, and 5mg strengths.
    *   **Contact**: 844-834-0530

## Why There's a Shortage

The FDA source data lists the reason for this ongoing shortage as **"Other."** No further specific details regarding manufacturing delays or demand increases were provided in the official database entry.

## What Patients Should Do

If you are affected by this shortage, consider the following steps:
1.  **Consult your pharmacist**: They can check current stock for specific National Drug Codes (NDCs) and may know which manufacturers are currently delivering to their location.
2.  **Contact your healthcare provider**: Discuss the availability of different strengths or alternative treatment plans if your specific dosage is unavailable.
3.  **Contact manufacturers**: Use the contact information provided above to inquire about the most recent availability updates for your specific prescription.

***Disclaimer:** Patients should always consult with their healthcare provider or pharmacist regarding medication changes or treatment alternatives. Do not adjust your dosage without medical supervision.* 

## Source

Data provided by the **FDA Drug Shortage Database**.